At the inaugural Animal Longevity Summit in Toronto, researchers discussed advances in animal ageing, including gene therapies for dogs and treatments for age-related diseases in cats.
Growing investment is supporting research into extending pets’ healthy lifespans through new medical treatments and improved nutrition.
San Diego-based Rejuvenate Bio is developing gene therapy for a common canine heart condition, while Genflow Biosciences is researching treatments targeting ageing and muscle loss in dogs.
The Cat Health Company has two experimental compounds undergoing clinical trials for age-related feline diseases. Researchers are also exploring partnerships with biotechnology companies to fund further studies.















Follow us on social media